Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vanda Pharmaceuticals (VNDA) Income towards Parent Company: 2010-2025

Historic Income towards Parent Company for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Sep 2025 value amounting to -$22.6 million.

  • Vanda Pharmaceuticals' Income towards Parent Company fell 324.23% to -$22.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.2 million, marking a year-over-year decrease of 413.85%. This contributed to the annual value of -$18.9 million for FY2024, which is 853.29% down from last year.
  • According to the latest figures from Q3 2025, Vanda Pharmaceuticals' Income towards Parent Company is -$22.6 million, which was up 16.92% from -$27.2 million recorded in Q2 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' Income towards Parent Company peaked at $9.6 million during Q2 2021, and registered a low of -$29.5 million during Q1 2025.
  • For the 3-year period, Vanda Pharmaceuticals' Income towards Parent Company averaged around -$8.7 million, with its median value being -$4.5 million (2024).
  • Its Income towards Parent Company has fluctuated over the past 5 years, first spiked by 1,856.46% in 2021, then tumbled by 3,057.78% in 2024.
  • Vanda Pharmaceuticals' Income towards Parent Company (Quarterly) stood at $7.1 million in 2021, then declined by 2.96% to $6.9 million in 2022, then crashed by 134.71% to -$2.4 million in 2023, then slumped by 105.44% to -$4.9 million in 2024, then plummeted by 324.23% to -$22.6 million in 2025.
  • Its Income towards Parent Company stands at -$22.6 million for Q3 2025, versus -$27.2 million for Q2 2025 and -$29.5 million for Q1 2025.